Home
About
Overview
Sharing Data
ORCID
Help
History (3)
APOBEC Deaminases
Clinically relevant genetic variations in drug metabolizing enzymes.
The oral microbiota in patients with pancreatic cancer, patients with IPMNs, and controls: a pilot study.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Clinically relevant genetic variations in drug metabolizing enzymes.
Clinically relevant genetic variations in drug metabolizing enzymes. Curr Drug Metab. 2011 Jun; 12(5):487-97.
View in:
PubMed
subject areas
Biomarkers, Pharmacological
Drug Labeling
Drug Therapy
Drug-Related Side Effects and Adverse Reactions
Genetic Variation
Humans
Inactivation, Metabolic
Pharmaceutical Preparations
Pharmacogenetics
United States
United States Food and Drug Administration
authors with profiles
Mary Dolan